Vinati Organics Ltd

Interglobe Aviation Ltd, Bayer CropScience Ltd, ITI Ltd, K E C International Ltd are among the other stocks to see a surge in volumes on BSE today, 27 May 2025.Vinati Organics Ltd saw volume of 2.35 lakh shares by 10:46 IST on BSE, a 37.49 fold spurt over two-week average daily volume of 6269 shares. The stock increased 0.68% to Rs.1,836.90. Volumes stood at 2699 shares in the last session.Interglobe Aviation Ltd notched up volume of 5.13 lakh shares by 10:46 IST on BSE, a 25.43 fold spurt over two-week average daily volume of 20180 shares. The stock slipped 2.00% to Rs.5,309.80. Volumes stood at 10229 shares in the last session.Bayer CropScience Ltd clocked volume of 25455 shares by 10:46 IST on BSE, a 22.82 times surge over two-week average daily volume of 1116 shares. The stock gained 11.17% to Rs.5,702.75. Volumes stood at 1842 shares in the last session.ITI Ltd registered volume of 5.29 lakh shares by 10:46 IST on BSE, a 9.02 fold spurt over two-week average daily volume of 58658 shares. The stock rose 9.36% to Rs.307.30. Volumes stood at 45100 shares in the last session.K E C International Ltd saw volume of 5.72 lakh shares by 10:46 IST on BSE, a 4.34 fold spurt over two-week average daily volume of 1.32 lakh shares. The stock increased 3.23% to Rs.889.10. Volumes stood at 1.61 lakh shares in the last session.Powered by Capital Market - Live

Vinati Organics has subscribed to the additional 4,10,25,000 fully paid-up equity shares of the face value of Rs 10/- each at par, amounting to Rs 41,02,50,000/- by way of subscription towards the rights issue of Veeral Organics, a Wholly Owned Subsidiary, the shares rank pari-passu to existing equity shares of the Company.Powered by Capital Market - Live

Net profit of Vinati Organics rose 18.14% to Rs 123.04 crore in the quarter ended March 2025 as against Rs 104.15 crore during the previous quarter ended March 2024. Sales rose 17.84% to Rs 648.46 crore in the quarter ended March 2025 as against Rs 550.31 crore during the previous quarter ended March 2024. For the full year,net profit rose 25.47% to Rs 405.25 crore in the year ended March 2025 as against Rs 322.98 crore during the previous year ended March 2024. Sales rose 18.33% to Rs 2248.17 crore in the year ended March 2025 as against Rs 1899.96 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales648.46550.31 18 2248.171899.96 18 OPM %27.8227.24 -25.8424.72 - PBDT186.42158.68 17 624.71504.89 24 PBT163.90139.13 18 536.18431.97 24 NP123.04104.15 18 405.25322.98 25 Powered by Capital Market - Live

Vinati Organics announced that the Board of Directors of the Company at its meeting held on 15 May 2025, has recommended a Final Dividend of Rs.7.50 per share (i.e.750%), subject to the approval of the shareholders.Powered by Capital Market - Live

Vinati Organics will hold a meeting of the Board of Directors of the Company on 15 May 2025.Powered by Capital Market - Live

The new entity was incorporated on 13 February 2025, with an authorized share capital of 5,000 shares at $100 par value each. The US subsidiary will focus on the processing, distribution, and sale of chemical solutions, including raw material acquisition and processing into finished goods. The company has initially subscribed to 10 shares at $100 per share in cash consideration, maintaining 100% ownership of the subsidiary. The expansion aligns with Vinati Organics' strategy to explore opportunities in the US market and enhance its specialty chemicals business presence. The subsidiary's incorporation complies with India's Foreign Exchange Management Regulations, Reserve Bank of India guidelines, and applicable US regulatory requirements. This development follows the company's earlier announcement on February 1, 2025, regarding its plans to establish a US subsidiary. The new entity will also handle the manufacturing and sale of Vinati Organics' products in the US market. Vinati Organics is one of India's leading manufacturers and exporters of specialty organic intermediaries, monomers, and polymers. On a consolidated basis, Vinati Organics's net profit gained 21.78% to Rs 93.70 crore in Q3 FY25 as against Rs 76.94 crore in Q2 FY25. Revenue from operations spiked 16.44% to Rs 521.68 crore in Q3 FY25 over Q2 FY25. Shares of Vinati Organics declined 3.63% to Rs 1,533.20 on the BSE.Powered by Capital Market - Live

Net profit of Vinati Organics rose 21.78% to Rs 93.70 crore in the quarter ended December 2024 as against Rs 76.94 crore during the previous quarter ended December 2023. Sales rose 16.45% to Rs 521.68 crore in the quarter ended December 2024 as against Rs 447.99 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales521.68447.99 16 OPM %27.2925.59 - PBDT148.94122.47 22 PBT126.62103.14 23 NP93.7076.94 22 Powered by Capital Market - Live

On a consolidated basis, Vinati Organics's net profit gained 21.78% to Rs 93.70 crore in Q3 FY25 as against Rs 76.94 crore in Q2 FY25. Revenue from operations spiked 16.44% to Rs 521.68 crore in Q3 FY25 over Q2 FY25. PBT jumped 22.76% to Rs 126.62 crore in Q3 FY25 over Q2 FY25. On a year-on-year basis, the company's consolidated net profit fell 10.21% while revenue from operations tumbled 5.71% in Q3 FY25. PBT slipped 5.18% YoY. Total expenses dropped by 9.10% to Rs 401.73 crore in the third quarter from Rs 441.99 crore recorded in the same period last year. This was primarily due to lower raw material costs (down 13.99% YoY) and lower power and fuel costs (down 4.61% YoY). Vinati Organics is one of India's leading manufacturers and exporters of specialty organic intermediaries, monomers, and polymers.Powered by Capital Market - Live

Vinati Organics will hold a meeting of the Board of Directors of the Company on 1 February 2025.Powered by Capital Market - Live

Vinati Organics has appointed Amit Thanawala (DIN: 10864545) as an Additional Director designated as Whole Time Director of the Company with effect from 13 December 2024, for a term of 5 (Five) consecutive years, subject to the approval of the shareholders. Powered by Capital Market - Live